The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids

Metabolism: Clinical and Experimental

Volumn 59, Issue 1, 2010, Pages 93-99

  Chang, Yi Cheng ^a   Chang, Tien Jyun ^a   Lee, Wei Jei ^b   Chuang, Lee Ming ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b MIN SHENG GENERAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; URIC ACID;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN TISSUE; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; OBESITY; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT;

ADIPOSE TISSUE; ADULT; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; POLYMERASE CHAIN REACTION;

EID: 72049100388     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.07.011     Document Type: Article

References (32)

1. Frayn K.N., Karpe F., Fielding B.A., Macdonald I.A., and Coppack S.W. Integrative physiology of human adipose tissue. Int J Obes 27 (2005) 875-888
2. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307 (2005) 426-430
3. Pagano C., Pilon C., Olivieri M., Mason P., Fabris R., Serra R., et al. Reduced plasma visfatin/pre B-cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab 91 (2006) 3165-3170
4. Berndt J., Klöting N., Kralisch S., Kovacs P., Fasshauer M., Schön M.R., et al. Plasma visfatin concentrations and fat-depot specific mRNA expression in humans. Diabetes 54 (2005) 2911-2916
5. Varma V., Yao-Borengasser A., Rasouli N., Bodles A.M., Phanavanh B., Lee M.J., et al. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. J Clin Endocrinol Metab 92 (2007) 666-672
6. Böttcher Y., Teupser D., Enigk B., Berndt J., Klöting N., and Schön M.R. Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans. J Clin Endocrinol Metab 91 (2006) 2725-2731
7. Fain J.N., Sacks H.S., Buehrer B., Bahouth S.W., Garrett E., Wolf R.Y., et al. Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots. Int J Obes 32 (2008) 810
8. Hammarstedt A., Pihlajamäki J., Rotter Sopasakis V., Gogg S., Jansson P.A., and Laakso M. Visfatin is an adipokine, but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab 91 (2006) 1181-1184
9. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., et al. Retraction of "Visfatin: a protein secreted by visceral fat that mimics the effects of insulin". Science 318 (2007) 565
10. Dahl T.B., Yndestad A., Skjelland M., Øie E., Dahl A., Michelsen A., et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 115 (2007) 972-980
11. Brentano F., Schorr O., Ospelt C., Stanczyk J., Gay R.E., Gay S., et al. Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis Rheum 56 (2007) 2829-2839
12. Jia S.H., Li Y., Parodo J., Kapus A., Fan L., Rotstein O.D., et al. Pre-B cell colony enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 113 (2004) 1318-1327
13. Moschen A.R., Kaser A., Enrich B., Mosheimer B., Theurl M., and Niederegger H. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 178 (2007) 1748-1758
14. Curat C.A., Wegner V., Sengenès C., Miranville A., Tonus C., and Busse R. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 49 (2006) 744-747
15. Greaves D.R., and Gordon S. Macrophage-specific gene expression: current paradigms and future challenges. Int J Hematol 76 (2002) 6-15
16. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
17. Pei D., Jones C.N., Bhargava R., Chen Y.D., and Reaven G.M. Evaluation of octreotide to assess insulin mediated glucose disposal by the insulin suppression test. Diabetologia 37 (1994) 843-845
18. Busso N., Karababa M., Nobile M., Rolaz A., Van Gool F., Galli M., et al. Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD. PLoS ONE 3 (2008) e2267
19. Sandeep S., Velmurugan K., Deepa R., and Mohan V. Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians. Metabolism 56 (2007) 565-570
20. Chen M.P., Chung F.M., Chang D.M., Tsai J.C., Huang H.F., Shin S.J., et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 91 (2006) 295-299
21. Retnakaran R., Youn B.S., Liu Y., Hanley A.J., Lee N.S., Park J.W., et al. Correlation of circulating full-length visfatin (PBEF/Nampt) with metabolic parameters in subjects with and without diabetes: a cross-sectional study. Clin Endocrinol 69 (2008) 885-893
22. Tan B.K., Chen J., Digby J.E., Keay S.D., Kennedy C.R., and Randeva H.S. Increased visfatin mRNA and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin. J Clin Endocrinol Metab 91 (2006) 5022-5028
23. Kowalska I., Straczkowski M., Nikolajuk A., Adamska A., Karczewska-Kupczewska M., Otziomek E., et al. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Hum Reprod 22 (2007) 1824-1829
24. Chan T.F., Chen Y.L., Chen H.H., Lee C.H., Jong S.B., and Tsai E.M. Increased plasma visfatin concentrations in women with polycystic ovary syndrome. Fertil Steril 88 (2007) 401-405
25. Krzyzanowska K., Krugluger W., Mittermayer F., Rahman R., Haider D., Shnawa N., et al. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci 110 (2006) 605-609
26. Zhong M., Tan H.W., Gong H.P., Wang S.F., Zhang Y., and Zhang W. Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis. Clin Endocrinol 69 (2008) 878-884
27. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112 (2008) 1796-1808
28. Gustafson B., Hammarstedt A., Andersson C.X., and Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 27 (2007) 2276-2283
29. Araki S., Dobashi K., Kubo K., Kawagoe R., Yamamoto Y., Kawada Y., et al. Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children. Obesity 16 (2008) 384-388
30. Sun G., Bishop J., Khalili S., Vasdev S., Gill V., Pace D., et al. Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men. Am J Clin Nutr 85 (2007) 399-404
31. Wajchernberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21 (2000) 697-738
32. Porter S.A., Massaro J.M., Hoffmann U., Vasan R.S., O'Donnell C.J., and Fox C.S. Subcutaneous abdominal adipose tissue: a protective fat depot?. Diabetes Care (2009) [Epub ahead of print]